[{"address1": "219 Terry Ave. N", "address2": "Suite 300", "city": "Seattle", "state": "WA", "zip": "98109", "country": "United States", "phone": "206 378 0400", "website": "https://kinetabio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Seattle, Washington.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Craig W. Philips", "age": 62, "title": "President & Secretary", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 541671, "exercisedValue": 0, "unexercisedValue": 24150}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.561, "open": 0.5581, "dayLow": 0.5268, "dayHigh": 0.61, "regularMarketPreviousClose": 0.561, "regularMarketOpen": 0.5581, "regularMarketDayLow": 0.5268, "regularMarketDayHigh": 0.61, "forwardPE": -0.43696296, "volume": 66936, "regularMarketVolume": 66936, "averageVolume": 383648, "averageVolume10days": 245300, "averageDailyVolume10Day": 245300, "bid": 0.5676, "ask": 0.6247, "bidSize": 100, "askSize": 100, "marketCap": 6695660, "fiftyTwoWeekLow": 0.334, "fiftyTwoWeekHigh": 5.39, "priceToSalesTrailing12Months": 1.2303675, "fiftyDayAverage": 0.76934, "twoHundredDayAverage": 2.417365, "currency": "USD", "enterpriseValue": 2169755, "profitMargins": -2.59078, "floatShares": 6737638, "sharesOutstanding": 11350500, "sharesShort": 95121, "sharesShortPriorMonth": 75256, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.0087, "heldPercentInsiders": 0.29725, "heldPercentInstitutions": 0.11446, "shortRatio": 0.21, "shortPercentOfFloat": 0.012200001, "bookValue": 0.278, "priceToBook": 2.1219425, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -14099000, "trailingEps": -1.28, "forwardEps": -1.35, "enterpriseToRevenue": 0.399, "enterpriseToEbitda": -0.138, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "KA", "underlyingSymbol": "KA", "shortName": "Kineta, Inc.", "longName": "Kineta, Inc.", "firstTradeDateEpochUtc": 1455201000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "709960ac-3b08-3407-99b9-a14d0009bc3c", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.5899, "targetHighPrice": 13.5, "targetLowPrice": 13.5, "targetMeanPrice": 13.5, "targetMedianPrice": 13.5, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 5783000, "totalCashPerShare": 0.528, "ebitda": -15714000, "totalDebt": 1317000, "quickRatio": 0.818, "currentRatio": 0.845, "totalRevenue": 5442000, "debtToEquity": 43.053, "revenuePerShare": 0.492, "returnOnAssets": -0.70911, "returnOnEquity": -3.69013, "freeCashflow": -10421500, "operatingCashflow": -16209000, "revenueGrowth": -1.0, "grossMargins": -0.65803003, "ebitdaMargins": -2.8875399, "operatingMargins": -2.8892002, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-04"}]